Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check5 days agoChange DetectedNotice added about a lapse in government funding with information to check cc.nih.gov and opm.gov; page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page now adds a 'Show glossary' option and updates footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with a 'No FEAR Act Data' notice. These are non-critical UI and metadata updates that do not affect core study content.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check48 days agoChange DetectedAdded a consolidated Locations section listing Alabama, California, North Carolina, and Tennessee. Removed the HHS Vulnerability Disclosure link and updated the page to revision v3.3.3.SummaryDifference0.4%

- Check69 days agoChange DetectedThe page now displays Revision: v3.3.2 and no longer shows Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays a new revision label: Revision: v3.3.1, and the previous label Revision: v3.2.0 has been removed. This is a minor update to the page's version information and does not alter study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedDeletion of the banner about government funding lapses and NIH operating status, which does not affect the study details or core information for NCT03347123. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.